Skip to main content
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc.

$13.04 -0.28 (-2.07%)
Market Cap
$1.12B
Shares
84.09M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1626971 CUSIP 221015100 13F (30d) 21 filings 21 filers Visit website Investor relations